These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7815101)

  • 1. Detection of biological activity in the cerebrospinal fluid of patients with central nervous system tumors.
    Tapper D; Cahan MA; Brem H
    J Neurooncol; 1994; 19(1):17-23. PubMed ID: 7815101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration.
    Almeida SM; Cunha DS; Yamada E; Doi EM; Ono M
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):720-4. PubMed ID: 18949270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
    Verheul C; Kleijn A; Lamfers MLM
    Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
    Mattox AK; Yan H; Bettegowda C
    Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
    Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
    Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.
    Patel AS; Allen JE; Dicker DT; Peters KL; Sheehan JM; Glantz MJ; El-Deiry WS
    Oncotarget; 2011 Oct; 2(10):752-60. PubMed ID: 21987585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
    Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
    Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
    Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
    Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.
    Almeida SM; Nanakanishi E; Conto AJ; Souza LP; Antonelli Filho D; Roda CD
    Arq Neuropsiquiatr; 2007 Sep; 65(3B):802-9. PubMed ID: 17952285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
    Cinque P; Brytting M; Vago L; Castagna A; Parravicini C; Zanchetta N; D'Arminio Monforte A; Wahren B; Lazzarin A; Linde A
    Lancet; 1993 Aug; 342(8868):398-401. PubMed ID: 8101902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
    Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
    J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
    Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
    J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors.
    Glick RP; Unterman TG
    Neurosurgery; 1995 Mar; 36(3):556-63; discussion 563-4. PubMed ID: 7753356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
    Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
    J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
    Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
    Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
    Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
    Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
    Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
    Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.